Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-03-001684
Filing Date
2003-04-14
Accepted
2003-04-14 15:06:44
Documents
1
Period of Report
2003-02-21

Document Format Files

Seq Description Document Type Size
1 form4.txt 4/A 10909
  Complete submission text file 0001144204-03-001684.txt   13135
Mailing Address 375 PARK AVE NEW YORK NY 10152
Business Address 375 PARK AVE SUITE 1501 NEW YORK NY 10152 2128324366
ROSENWALD LINDSAY A MD (Reporting) CIK: 0000941841 (see all company filings)

 

Mailing Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019 2125544555
MANHATTAN PHARMACEUTICALS INC (Subject) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 000-27282 | Film No.: 03648507
SIC: 2834 Pharmaceutical Preparations